All stock lists
Shoals Technologies Group, Inc. (NASDAQ:SHLS)
US · Delayed Price · Currency is USD
Energy · Solar
7.49-0.09 (-1.22%)
Market cap
$1.26B
Health Score
Analyst consensus
Listed since
Jan 28, 2021
Website
Insider Score
––Not scored
SHLS Insider Score
Insiders here have filed 2 Form 4s in the last 90 days, but all of them are share awards, grants or other non-market transactions. Those are compensation, not a decision to buy, so they are not scored.
SHLS analyst forecast
SHLS analyst consensus
Moderate Buy5 ratings
Buy 4 Hold 1 Sell 0
Based on each firm’s most recent rating in the last 3 months — one vote per firm, so a desk that reiterates weekly does not count three times.
SHLS 12-month price target
No published price targets in the last 12 months.
Best analysts covering SHLS
- Jefferies100%success rate · 2 calls
- Guggenheim83%success rate · 6 calls
- Goldman Sachs80%success rate · 10 calls
- Barclays67%success rate · 3 calls
Measured by us from each firm’s own rating dates and this stock’s split- and dividend-adjusted closes. How we calculate this.
SHLS analyst ratings
| Firm | Price target | Action | ||||
|---|---|---|---|---|---|---|
| — | JP Morgan | Overweight | — | — | Reiterated | 2026-10-19 |
| — | Mizuho | Neutral | — | — | Reiterated | 2026-10-16 |
| — | Jefferies | Buy | — | — | Reiterated | 2026-10-14 |
| — | Barclays | Overweight | — | — | Reiterated | 2026-10-08 |
| — | RBC Capital | Outperform | — | — | Reiterated | 2026-08-05 |
| — | Goldman Sachs | Buy | — | — | Reiterated | 2026-07-21 |
| — | Jefferies | Buy | — | — | Reiterated | 2026-07-14 |
| — | Barclays | Overweight | — | — | Reiterated | 2026-06-26 |
| — | Wells Fargo | Equal Weight | — | — | Reiterated | 2026-06-11 |
| — | UBS | Buy | — | — | Reiterated | 2026-05-07 |
| — | Needham | Buy | — | — | Reiterated | 2026-05-06 |
| — | JP Morgan | Overweight | — | — | Reiterated | 2026-05-06 |
| — | Citigroup | Neutral | — | — | Reiterated | 2026-05-06 |
| — | JP Morgan | Overweight | — | — | Reiterated | 2026-04-16 |
| — | Jefferies | Buy | — | — | Reiterated | 2026-03-11 |
| — | Citigroup | Neutral | — | — | Reiterated | 2026-02-26 |
| — | Roth Capital | Buy | — | — | Reiterated | 2026-02-25 |
| — | UBS | Buy | — | — | Reiterated | 2026-02-25 |
| — | Barclays | Overweight | — | — | Reiterated | 2026-02-25 |
| — | RBC Capital | Outperform | — | — | Reiterated | 2026-02-25 |
| — | Morgan Stanley | Equal Weight | — | — | Reiterated | 2026-02-25 |
| — | Wells Fargo | Equal Weight | — | — | Reiterated | 2026-02-25 |
| — | Guggenheim | Buy | — | — | Reiterated | 2026-02-25 |
| — | Needham | Buy | — | — | Reiterated | 2026-02-25 |
| — | Morgan Stanley | Equal Weight | — | — | Downgraded | 2025-12-16 |
| — | Guggenheim | Buy | — | — | Reiterated | 2025-11-11 |
| — | Wells Fargo | Equal Weight | — | — | Reiterated | 2025-11-06 |
| — | UBS | Buy | — | — | Reiterated | 2025-11-05 |
| — | Goldman Sachs | Buy | — | — | Reiterated | 2025-11-05 |
| — | Roth Capital | Buy | — | — | Reiterated | 2025-11-05 |
| — | Morgan Stanley | Overweight | — | — | Reiterated | 2025-10-16 |
| — | JP Morgan | Overweight | — | — | Reiterated | 2025-10-16 |
| — | Barclays | Overweight | — | — | Upgraded | 2025-10-02 |
| — | UBS | Buy | — | — | Reiterated | 2025-10-01 |
| — | JP Morgan | Overweight | — | — | Reiterated | 2025-09-19 |
| — | Goldman Sachs | Buy | — | — | Reiterated | 2025-09-11 |
| — | Jefferies | Buy | — | — | Reiterated | 2025-09-08 |
| — | Guggenheim | Buy | — | — | Reiterated | 2025-08-06 |
| — | UBS | Buy | — | — | Reiterated | 2025-08-06 |
| — | Barclays | Equal Weight | — | — | Reiterated | 2025-07-18 |
| — | Jefferies | Buy | — | — | Upgraded | 2025-07-07 |
| — | Mizuho | Outperform | — | — | Reiterated | 2025-06-02 |
| — | Exane BNP Paribas | Underperform | — | — | Downgraded | 2025-05-15 |
| — | Guggenheim | Buy | — | — | Reiterated | 2025-05-09 |
| — | Citigroup | Neutral | — | — | Reiterated | 2025-05-07 |
| — | Goldman Sachs | Buy | — | — | Reiterated | 2025-05-07 |
| — | Jefferies | Hold | — | — | Reiterated | 2025-03-12 |
| — | Goldman Sachs | Buy | — | — | Reiterated | 2025-02-26 |
| — | Piper Sandler | Overweight | — | — | Reiterated | 2025-02-26 |
| — | RBC Capital | Outperform | — | — | Reiterated | 2025-02-26 |
| — | Roth MKM | Neutral | — | — | Reiterated | 2025-02-26 |
| — | UBS | Buy | — | — | Reiterated | 2025-02-26 |
| — | Oppenheimer | Outperform | — | — | Reiterated | 2025-01-28 |
| — | Mizuho | Outperform | — | — | Reiterated | 2025-01-24 |
| — | JP Morgan | Overweight | — | — | Reiterated | 2025-01-23 |
| — | Goldman Sachs | Buy | — | — | Reiterated | 2025-01-22 |
| — | Barclays | Equal Weight | — | — | Reiterated | 2025-01-17 |
| — | Truist Securities | Buy | — | — | Reiterated | 2025-01-16 |
| — | Goldman Sachs | Buy | — | — | Reiterated | 2024-12-17 |
| — | Morgan Stanley | Overweight | — | — | Upgraded | 2024-12-17 |
SHLS earnings vs. estimates
| Quarter | EPS est. | EPS actual | Revenue est. | Revenue actual |
|---|---|---|---|---|
| 2026-02-24 | 0.14 | 0.10 | $144.9M | $148.3M |
| 2026-05-05 | 0.06 | 0.07 | $129.2M | $140.6M |
| 2026-08-04 | 0.10 | 0.12 | $160.0M | $163.4M |
| 2026-11-04 | 0.12 | 0.00 | $161.8M | $0 |
Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.